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   Estramustine phosphate （Est；acyt） w4s administ’gyed per os to 23 patients with carcinoma of
the prostate and its therapeutic effect was investigated． The following results were obtained．
   1．・ Group 1 consisting of 13 cases without previous treatment showed good response in all．
   2． Group II consisting of 10 cases resistant to the hormone therapy showed response in 300／．
of them．
   3． There was an obvious difference between Group 1 and II in the improvement of general
・・ぬditi・・，・・bjecti…ymp・・m・，．・m・un・・f・c・圭d・・1・・i・・，・n・嘔ac五d・nd・lk・li・・ph・・ph・…e
Ievel， local findings， metastatic lesions and urethrographic findings． For example， urethrographic
improvement was obtained in 83．30／， of Group 1 cases and・ 25．00／． of Group II cases．
   4． Of side effects， the most frequently seen was that of the breast． Others were also related
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with the estrogenic effect． The side effects upon the liver and hemic system must be considered．
  5． Estracyt is a useful drug for carcinoma of the prostate not only in previously untreated cases
but in hormone－resistant cases． lt is， however， uneffective for the advanced cases． Choice of the
































Co．operative Urological Rescarch Groupにならい2），
stage A， B， C， Dにわけたが，血清酸フォスファタ
ーゼの明らかな上昇が認められた場合には転移巣が確
認できなくともstage Dとして取扱った．これによ
ると工群ではstagc C 2例， stage D 11例， H群では
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        （6）の項目についてはそれぞれ
        ・…・・著効（掛）
        ……有効（甘〉
        …・・やや有効（＋）
  不変ないし増悪……無効（一）
とした．
 （7）腰   痛
 著効   ほとんど消失．
 有効   かなり改善
  やや有効 軽度改善。
 無効   不変ないし増悪’
 （8）局所所見
① 大きさ
 著効   90％以上の縮小．




























  著効   膀胱底下降，尿道前立腺部変形改善顕
       著．
  有効   下降，改善中等度・
  やや有効 下降，改善軽度．








































Table 1． Summary and clinical results oll gr．oup工patients
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1 72 CmD adenocd．
2 74 D adenoca．
3 72 B－C adenoca．
4 72 C－D undiff．
5 72 C adenoca．
6 ．70 C－D adenoca．
7 ’72D ．C－D ．P adenoca．
．．8@． 65 D adenoca．
g so c－b aden．oca．
・iO． 69 D und・iff．
6T 21d“
6T ’ 65d｛4T 14d3T 300d
4士28d
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Table 3． Comparison of the cJinical results on 2 groups
全   自 覚 症   残
身  腰  排  頻
     尿状     困
態  痛  難  尿  尿
貧 アォスファターゼ 局所所見  転
  酸礎硬移







7  8   2   5
1  1  4   0
1  1  4  3
2   2   2   1
2   1   1  4
2   4   2
5  0   2
4   0   2
2  0  5
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